drugset / Trial / NCT00678561

Topical CP-690,550 For Chronic Plaque Psoriasis

NCT00678561

Phase 2 Completed 81 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.

Timeline

Start
2008-10-13
Primary completion
2009-07-09
Completion
2009-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule 0.02 % Topical
Subject Tofacitinib Small molecule 0.2 % Topical
Subject Tofacitinib Small molecule 2 % Topical

Indications